# Commission Implementing Decision of 19 December 2011 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2011 and amending Decision 2010/712/EU as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2011) 9478) (2011/862/EU), Article 8: Amendments to Decision 2010/712/EU

Extent: E+W+S+N.I.

Decision 2010/712/EU is amended as follows:
1.. Article 1 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 4 600 000 for Spain;
(ii) EUR 3 000 000 for Italy;
(iii) EUR 90 000 for Cyprus;
(iv) EUR 1 040 000 for Portugal;
(v) EUR 1 350 000 for the United Kingdom.’;
(c) in paragraph 3, points (a) to (d) are replaced by the following:
(a) for a rose bengal test ‘EUR 0,24 per test;
(b) for a SAT test EUR 0,24 per test;
(c) for a complement fixation test EUR 0,48 per test;
(d) for an ELISA test EUR 1,2 per test’;
2.. Article 2 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 16 000 000 for Ireland;
(ii) EUR 18 500 000 for Spain;
(iii) EUR 5 500 000 for Italy;
(iv) EUR 1 440 000 for Portugal;
(v) EUR 26 500 000 for the United Kingdom.’;
(c) in paragraph 3, points (a) and (b) are replaced by the following:
(a) for a tuberculin test ‘EUR 2,4 per test;
(b) for a gamma-interferon test EUR 6 per test’;
3.. Article 3 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 160 000 for Greece;
(ii) EUR 9 200 000 for Spain;
(iii) EUR 4 200 000 for Italy;
(iv) EUR 85 000 for Cyprus;
(v) EUR 2 260 000 for Portugal.’;
(c) in paragraph 3, points (a) and (b) are replaced by the following:
(a) for a rose bengal test ‘EUR 0,24 per test;
(b) for a complement fixation test EUR 0,48 per test;’;
4.. Article 4 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 420 000 for Belgium;
(ii) EUR 10 000 for Bulgaria;
(iii) EUR 1 700 000 for the Czech Republic;
(iv) EUR 0 for Denmark;
(v) EUR 400 000 for Germany;
(vi) EUR 10 000 for Estonia;
(vii) EUR 10 000 for Ireland;
(viii) EUR 100 000 for Greece;
(ix) EUR 5 200 000 for Spain;
(x) EUR 3 000 000 for France;
(xi) EUR 300 000 for Italy;
(xii) EUR 20 000 for Latvia;
(xiii) EUR 5 000 for Lithuania;
(xiv) EUR 60 000 for Hungary;
(xv) EUR 10 000 for Malta;
(xvi) EUR 50 000 for the Netherlands;
(xvii) EUR 160 000 for Austria;
(xviii) EUR 50 000 for Poland;
(xix) EUR 1 650 000 for Portugal;
(xx) EUR 100 000 for Romania;
(xxi) EUR 50 000 for Slovenia;
(xxii) EUR 60 000 for Slovakia;
(xxiii) EUR 20 000 for Finland;
(xxiv) EUR 20 000 for Sweden.’;
(c) in paragraph 3, points (a) to (f) are replaced by the following:
(a) for an ELISA test ‘EUR 3 per test;
(b) for a PCR test EUR 12 per test;
(c) for the purchase of monovalent vaccines EUR 0,36 per dose;
(d) for the purchase of bivalent vaccines EUR 0,54 per dose;
(e) for the administration of vaccines to bovine animals EUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used;
(f) for the administration of vaccines to ovine or caprine animals EUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.’;
5.. Article 5 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 1 200 000 for Belgium;
(ii) EUR 25 000 for Bulgaria;
(iii) EUR 2 100 000 for the Czech Republic;
(iv) EUR 340 000 for Denmark;
(v) EUR 1 000 000 for Germany;
(vi) EUR 40 000 for Estonia;
(vii) EUR 120 000 for Ireland;
(viii) EUR 1 000 000 for Greece;
(ix) EUR 1 300 000 for Spain;
(x) EUR 660 000 for France;
(xi) EUR 1 700 000 for Italy;
(xii) EUR 150 000 for Cyprus;
(xiii) EUR 1 650 000 for Latvia;
(xiv) EUR 20 000 for Luxembourg;
(xv) EUR 2 400 000 for Hungary;
(xvi) EUR 150 000 for Malta;
(xvii) EUR 3 900 000 for the Netherlands;
(xviii) EUR 1 200 000 for Austria;
(xix) EUR 4 800 000 for Poland;
(xx) EUR 65 000 for Portugal;
(xxi) EUR 500 000 for Romania;
(xxii) EUR 120 000 for Slovenia;
(xxiii) EUR 600 000 for Slovakia;
(xxiv) EUR 75 000 for the United Kingdom.’;
(c) in paragraph 3, points (a) to (e) are replaced by the following:
(a) for a bacteriological test (cultivation/isolation) ‘EUR 8,4 per test;
(b) for the purchase of vaccine EUR 0,06 per dose;
(c) for serotyping of relevant isolates of Salmonella spp. EUR 24 per test;
(d) for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock EUR 6 per test;
(e) for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella EUR 6 per test.’;
6.. Article 6 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 120 000 for Bulgaria;
(ii) EUR 1 600 000 for Germany;
(iii) EUR 240 000 for France;
(iv) EUR 160 000 for Italy;
(v) EUR 700 000 for Hungary;
(vi) EUR 700 000 for Romania;
(vii) EUR 30 000 for Slovenia;
(viii) EUR 300 000 for Slovakia.’;
(c) in paragraph 3, ‘EUR 2,5’ is replaced by ‘EUR 3’;
7.. Article 8 is amended as follows:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(c) is replaced by the following:
(c) ‘shall not exceed the following:
(i) EUR 90 000 for Belgium;
(ii) EUR 25 000 for Bulgaria;
(iii) EUR 70 000 for the Czech Republic;
(iv) EUR 80 000 for Denmark;
(v) EUR 300 000 for Germany;
(vi) EUR 10 000 for Estonia;
(vii) EUR 75 000 for Ireland;
(viii) EUR 50 000 for Greece;
(ix) EUR 150 000 for Spain;
(x) EUR 150 000 for France;
(xi) EUR 1 000 000 for Italy;
(xii) EUR 20 000 for Cyprus;
(xiii) EUR 45 000 for Latvia;
(xiv) EUR 10 000 for Lithuania;
(xv) EUR 10 000 for Luxembourg;
(xvi) EUR 360 000 for Hungary
(xvii) EUR 20 000 for Malta;
(xviii) EUR 360 000 for the Netherlands;
(xix) EUR 60 000 for Austria;
(xx) EUR 100 000 for Poland;
(xxi) EUR 45 000 for Portugal;
(xxii) EUR 180 000 for Romania;
(xxiii) EUR 50 000 for Slovenia;
(xxiv) EUR 15 000 for Slovakia;
(xxv) EUR 25 000 for Finland;
(xxvi) EUR 50 000 for Sweden;
(xxvii) EUR 160 000 for the United Kingdom.’;
(c) in paragraph 3, points (a) to (e) are replaced by the following:
(a) ELISA test ‘EUR 2,4 per test;
(b) agar gel immune diffusion test EUR 1,44 per test;
(c) HI test for H5/H7 EUR 14,40 per test;
(d) virus isolation test EUR 48 per test;
(e) PCR test EUR 24 per test.’;
8.. Article 9 is amended as follows:
(a) in paragraph 2(c), ‘50 %’ is replaced by ‘60 %’;
(b) paragraph 2(d) is replaced by the following:
(d) ‘shall not exceed the following:
(i) EUR 1 900 000 for Belgium;
(ii) EUR 330 000 for Bulgaria;
(iii) EUR 1 030 000 for the Czech Republic;
(iv) EUR 1 370 000 for Denmark;
(v) EUR 7 750 000 for Germany;
(vi) EUR 330 000 for Estonia;
(vii) EUR 4 000 000 for Ireland;
(viii) EUR 2 000 000 for Greece;
(ix) EUR 6 650 000 for Spain;
(x) EUR 18 850 000 for France;
(xi) EUR 6 000 000 for Italy;
(xii) EUR 1 700 000 for Cyprus;
(xiii) EUR 320 000 for Latvia;
(xiv) EUR 720 000 for Lithuania;
(xv) EUR 125 000 for Luxembourg;
(xvi) EUR 1 180 000 for Hungary;
(xvii) EUR 25 000 for Malta;
(xviii) EUR 3 530 000 for the Netherlands;
(xix) EUR 1 800 000 for Austria;
(xx) EUR 3 440 000 for Poland;
(xxi) EUR 1 800 000 for Portugal;
(xxii) EUR 1 000 000 for Romania;
(xxiii) EUR 250 000 for Slovenia;
(xxiv) EUR 550 000 for Slovakia;
(xxv) EUR 580 000 for Finland;
(xxvi) EUR 850 000 for Sweden;
(xxvii) EUR 6 500 000 for the United Kingdom.’;
(c) in paragraph 3(d) ‘EUR 10’ is replaced by ‘EUR 12’;
9.. Article 10, paragraph 2(c) is amended as follows:
(a) in point (i) ‘EUR 1 800 000’ is replaced by ‘EUR 850 000’;
(b) in point (ii) ‘EUR 620 000’ is replaced by ‘EUR 570 000’;
(c) in point (iv) ‘EUR 7 110 000’ is replaced by ‘EUR 8 110 000’;
(d) in point (v) ‘EUR 5 000 000’ is replaced by ‘EUR 2 100 000’;
(e) in point (vii) ‘EUR 200 000’ is replaced by ‘EUR 290 000’;
10.. in Article 10 paragraph 4, ‘paragraphs 2 and 3’ is replaced by ‘paragraph 2(a), paragraph 2(b) and paragraph 3’;
11.. Article 11, paragraph 5(c) is amended as follows:
(a) in point (i) ‘EUR 2 250 000’ is replaced by ‘EUR 1 600 000’;
(b) in point (ii) ‘EUR 1 800 000’ is replaced by ‘EUR 1 500 000’;
(c) in point (v) ‘EUR 740 000’ is replaced by ‘EUR 850 000’;
12.. in Article 11 paragraph 7, ‘paragraphs 5 and 6’ is replaced by ‘paragraph 5(a), paragraph 5(b) and paragraph 6’.

---
Source: https://www.legislation.gov.uk/eudn/2011/862/article/8 (the official version)
Page: https://openlegislation.uk/eu-decision-2011-862/article-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.